会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • THERAPEUTIC COMPOUNDS
    • 治疗化合物
    • WO2005084653A2
    • 2005-09-15
    • PCT/GB2005000800
    • 2005-03-04
    • CAMBRIDGE BIOTECHNOLOGY LTDPRITCHARD MARTYNOUZMAN JACQUELINESAVORY EDWARDBROWN GILES
    • PRITCHARD MARTYNOUZMAN JACQUELINESAVORY EDWARDBROWN GILES
    • C07H19/16A61K31/00
    • C07H19/16
    • Use of compounds of general formula (A) as medicaments is described, in particular for the treatment of pain or inflammation; wherein: (I) when X = OH, R2 = NH2, R5 = CH2OH, R6 = H , R1 is C5-C6 alkoxy, OCH2Cyclopropyl, O-(2,2,3,3-tetrafluoro-cycloButyl), phenoxy, substituted phenoxy, OCH2CH2OH, or OCH2CHF2, (5-indanyl)oxy, C1, C2, C5, or C6 alkylamino, (R) or (S)-sec-Butylamino, C5 or C6 cycloalkylamino, exo-norbornane amino, (N-methyl, N-­isoamylamino), phenylamino, phenylamino with either rnethoxy or fluoro substituents, a C2 sulfone group, a C2 alkyl group, a cyano group, a CONH2 group, or 3,5-dimethylphenyl; or when X = H, R2 = NH2, R5 = CH2OH , R6 = H, R1 is n-hexyloxy; or (II) when X = OH , R1 = H, R5 = CH2OH, R6 = H, R2 is NMe2, N-(2-isopentenyl), piperazinyl, (N-Me, N-benzyl), (N-Me, N-CH2Ph(3-Br)), (N-Me, N-­CH2Ph(3-CF3)), or (N-Me, N-(2-rnethoxyethyl)), or OCH2Cyclopentyl; or (III) when X = OH, R5 = CONHR3, R6 = H: R1 is H, R3 is an isopropyl group, and R2 is either NH2 or a methylamino group (NHMe) or an isoamyl group (CH2CH2CHMe2); or R1 is H, R3 is H, and R2 is NH2; or R1 is OMe, R3 is Ph, and R2 is NH2; or R1 is NHCH2CH2CH2CH2CH2Me, R3 is CH2CH2CH2Me, and R2 is NH2; or (IV) when X = OH, R1 = H, R2 = NH2, R5 = CH2NHCOR.4, R6 = H, R4 is n-propyl or NHCH2CH3; or (V) when X = OH, R5 = CH2OH, R6 = H: R1 is NHCyclohexyl when R2 is NMe2; or R1 is OMe when R2 is NHBenzyl; or (VI) when X = OH , R2 = NH2, R5 = CH2OH, R6 = Me, R1 is NHCyclohexyl or NHCyclopentyl.
    • 描述了通式(A)的化合物作为药物的用途,特别是用于治疗疼痛或炎症; 其中:(I)X = OH时,R2 = NH2,R5 = CH2OH,R6 = H,R1为C5-C6烷氧基,OCH2环丙基,O-(2,2,3,3-四氟环丁基) 苯氧基,OCH2CH2OH或OCH2CHF2,(5-二氢化茚基)氧基,C1,C2,C5或C6烷基氨基,(R)或(S) - 仲丁氨基,C5或C6环烷基氨基,外降冰片烷基氨基,(N-甲基 ,N-异戊基氨基),苯基氨基,具有甲氧基或氟取代基的苯基氨基,C2砜基,C2烷基,氰基,CONH2基或3,5-二甲基苯基; 或当X = H时,R 2 = NH 2,R 5 = CH 2 OH,R 6 = H,R 1为正己氧基; 或(II)当X = OH时,R1 = H,R5 = CH2OH,R6 = H,R2是NMe2,N-(2-异戊烯基),哌嗪基,(N-Me,N-苄基),(N-Me, N-CH 2 Ph(3-Br)),(N-Me,N-CH 2 Ph(3-CF 3))或(N-Me,N-(2-甲氧基乙基))或OCH 2环戊基; 或(III)当X = OH时,R5 = CONHR3,R6 = H:R1是H,R3是异丙基,R2是NH2或甲基氨基(NHMe)或异戊基(CH2CH2CHMe2); 或R1为H,R3为H,R2为NH2; 或R1是OMe,R3是Ph,R2是NH2; 或R1是NHCH2CH2CH2CH2CH2Me,R3是CH2CH2CH2Me,R2是NH2; 或(IV)当X = OH时,R1 = H,R2 = NH2,R5 = CH2NHCOR4,R6 = H,R4为正丙基或NHCH2CH3; 或(Ⅴ)当X = OH时,R5 = CH2OH,R6 = H:当R2为NMe2时,R1为NHCyclohexyl; 或当R 2为NH苄基时,R 1为OMe; 或(Ⅵ)当X = OH时,R 2 = NH 2,R 5 = CH 2 OH,R 6 = Me,R 1为NHC环己基或NHC环戊基。